drugset / Trial / NCT06516861

Magnesium Sulphate and Lidocaine in Hemodynamic Changes and Cortisol Levels

NCT06516861

RandomizedParallel-groupDouble-blindPrevention

Summary

The sample was randomly divided into 3 groups consisting of patients who received Magnesium Sulfate 30 mg/Kg, Lidocaine 1.5 mg/Kg, and Control. These groups will be checked for hemodynamic changes and cortisol values.

Timeline

Start
2024-01-31
Primary completion
2024-02-01
Completion
2024-03-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 1.5 mg/kg Intravenous
Subject Magnesium Sulfate Other / unclassified 30 mg/kg Intravenous

Indications

No indication recorded.